Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05346055 · ClinicalTrials.gov registry record · NA

The Feasibility of Engage Therapy With Video Support for Homebound Older Adults

A NA study of Depression, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT05346055: Completed NA study of Depression, sponsored by Weill Medical College of Cornell University.

NCT05346055 is a NA study of Depression that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 8 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05346055, a NA study of Depression, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video social support (PRISM 2.0) among socially isolated/lonely case management clients who endorse depressive symptoms. Eligible participants will be offered the combination of Engage and Prism 2.0, called Engage-Prism. The investigators hypothesize that the intervention (Engage Therapy With Video Support) will be accepted by participants, improve depressive symptom, and be feasible to complete.

Primary Outcome

The CSQ is a 3 - item questionnaire assessing client satisfaction with the treatment provided partway through the treatment (6 weeks). Scores range from 3 (least satisfied) to 12 (most satisfied).

Conditions Studied

Interventions

  • BEHAVIORAL Engage Prism (2.0)

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2022-05-12
Est. Completion 2022-09-30
Phase NA

What the finished NCT05346055 record still lists

NCT05346055 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Engage Prism (2.0) is the first listed.

NCT05346055 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05346055 about?

NCT05346055 is a clinical study titled "The Feasibility of Engage Therapy With Video Support for Homebound Older Adults". The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video social support (PRISM 2.0) among socially isolated/lonely case management clients who endorse depress...

What is the current status of trial NCT05346055?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-05-12. Estimated completion is 2022-09-30.

What conditions does trial NCT05346055 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT05346055?

The interventions under investigation include: Engage Prism (2.0) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05346055?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05346055 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05346055's enrollment target sits among peer trials

8 667th of 679 higher than 10 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05346055, the US trial registry maintained by the National Library of Medicine. NCT05346055 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.